AzTrials
AzTrials

Type 2 DiabetesNCT06826703

The Effect of Motivational Interviewing on Diabetes Self-Management and Severity of Cyberchondria in Individuals With Diabetes

A study testing Experimental Group in people with Type 2 Diabetes and Motivation, run by Ataturk University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Objective: The aim of this study was to determine the effects of diabetes education given to individuals with diabetes using motivational interviewing technique based on the health promotion model on diabetes self-management and cyberchondria severity. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Type 2 Diabetes, Motivation, Self-management
What is being tested?
Experimental Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Feb 2025to 15 Aug 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Having diabetes for at least 6 months
  • Being over 18 years old
  • To have sufficient communication skills to answer verbal and written questions and fulfill instructions
  • Being literate
  • No physical, cognitive or mental impairment in answering the questions
  • Willingness to participate in research.

Who cannot join

  • Being under 18 years of age
  • Being hospitalized in inpatient treatment institutions due to DM or DM complications during the research process
  • The emergence of any health problem that prevents the person from continuing the research
  • Do not leave the study voluntarily.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Gülşen ALTUNTAŞ ÇALIM, PhD student contact

+905535383055

gulsenaltuntas13@hotmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Van Regional Training and Research Hospital Diabetes Polyclinic

    Van, Van, 65100

    Gülşen ALTUNTAŞ ÇALIM, PhD student, 05535383055, gulsenaltuntas13@hotmail.com

    Gülşen ALTUNTAŞ ÇALIM, PhD student

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: the Effect of Motivational Interviewing Based on Health Promotion Model on Diabetes Self-management and Cyberchondria Severity in Individuals With Diabetes

Objective: The aim of this study was to determine the effects of diabetes education given to individuals with diabetes using motivational interviewing technique based on the health promotion model on diabetes self-management and cyberchondria severity. Materials and Method: The population of the study consisted of 1000 individuals. The sample consisted of 64 individuals, 32 experimental and 32 control, who met the research criteria. The research will be conducted between 15.02.2025-15.03.2025 in Van Regional Training and Research Hospital Diabetes outpatient clinic. Data in the research; Descriptive Information Form, Diabetes Self-Management Scale (DMS), Cyberchondria Severity Scale-Short Form (CSS-SF) scales will be applied. Research experiment Motivational interviewing intervention based on the health belief model will be conducted once a week for 1 month. At the end of 1 month, both scales will be administered again to individuals in both experimental and control groups.

Read the detailed description

Objective: The aim of this study is to determine the effects of diabetes education given to individuals with diabetes using motivational interviewing technique based on the health promotion model on diabetes self-management and cyberchondria severity. Material and Method: The population of the study consisted of 1000 individuals. The sample consisted of 64 individuals, 32 experimental and 32 control, who met the research criteria. The research will be conducted in Van Regional Training and Research Hospital Diabetes outpatient clinic between 15.02.2025-15.03.2025. Data in the study; Descriptive Information Form, Diabetes Self-Management Scale (DMSS), Cyberchondria Severity Scale-Short Form (CSS-SF) scales will be applied. Research experiment The motivational interviewing intervention based on the health belief model will be conducted once a week for 1 month. At the end of 1 month, both The scales will be administered again to the individuals in both the experimental group and the control group. Descriptive statistical methods (number, percentage), chi-square test, independent t-test in groups and paired t-test will be used.

Being tested
Experimental Group
Keywords
cyberchondria violence, health belief model, self-management, type 2 diabetes, motivational interview
Medical subject headings
Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Experimental GroupOther

    Individuals will receive diabetes education with motivational interviewing technique based on health belief model.

Study groups in NCT06826703
Study groupRoleWhat they receive
group receiving diabetes education with motivational interviewing technique based on health belief mExperimentalPatient Introduction Form, Diabetes Self-Management Scale (DSMS), Cyberchondria Severity Scale-Short Form (CSS-SS-SF) scales will be applied to the experimental group before the training. Then, individuals in the experimental group will be given diabetes education one day a week with the motivational interviewing technique based on the health belief model. A total of 4 weeks of education will be given. After the end of the training, Patient Introduction Form, Diabetes Self-Management Scale (DMSS), Cyberchondria Severity Scale-Short Form (SCS-SF) scales will be applied.
Receives: Other: Experimental Group
group who did not receive diabetes education with motivational interviewing techniqueNo interventionPatient introduction form, Diabetes Self-Management Scale (DMSMS), Cyberchondria Severity Scale-Short Form (CSS-SS-SF) scales will be applied to the control group at the first encounter. After 1 month, the Patient Introduction Form, Diabetes Self-Management Scale (DMSS), Cyberchondria Severity Scale-Short Form (CSS-SF) scales will be applied again. No application will be made to the control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cyberchondria Severity Scale-Short Form (CSS-SF)

    The scale assesses the severity of cybercronyism. Items can be summed to form a total score. The lowest score that can be obtained from the scale is 0 and the highest score is 60.It consists of 12 items.

    • Extremism The incremental and repetitive nature of research 1, 3, 6
    • Anxiety Anxiety/anxiety as a result of research 4, 8, 9
    • Assurance Research that encourages individuals to seek professional medical advice 5, 11, 12
    • Coercion Web searches affecting all aspects of life 2, 7, 10

    Measured: one months

  2. Diabetes Self-Management Perception Scale (DSMAS)

    The scale consists of 8 items. PERCEPTION OF SELF-MANAGEMENT IN DIABETES SCALE (DÖYAS)

    Choose the option closest to you... Strongly disagree............. . (1) Disagree with ........................ ... (2) Undecided................................ (3) Agree......................... .... (4) Strongly agree...................(5) The minimum score that can be obtained from the scale is 8 and the maximum score is 40.. A high total score indicates that the individual's awareness in diabetes management is very good

    Measured: one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2025
  2. Study start15 Feb 2025
  3. Primary completion15 Aug 2025 (estimated)
  4. Study completion15 Aug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
the experimental group will be trained with motivational technique. the control group will not receive any intervention
Masking
None (open label)
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06826703
Sponsor's protocol ID
AU-SBF-GAÇ-02
Status last verified
Apr 2025
First submitted
10 Feb 2025
Last updated
30 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Experimental Group in people with Type 2 Diabetes and Motivation, run by Ataturk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Gülşen ALTUNTAŞ ÇALIM, PhD student (+905535383055, gulsenaltuntas13@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cyberchondria Severity Scale-Short Form (CSS-SF) (time frame: one months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in